NIFTY 50
26,046.95 (0.57%)
NIFTY IT
38,274.75 (0.47%)
NIFTY AUTO
27,820.85 (0.58%)
NIFTY FINANCIAL SERVICES
27,672.60 (0.40%)
NIFTY BANK
59,389.95 (0.30%)
NIFTY REALTY
886.55 (1.53%)
NIFTY ENERGY
35,039.85 (0.83%)
NIFTY METAL
10,536.45 (2.63%)
NIFTY FMCG
54,490.80 (-0.24%)
NIFTY HEALTH CARE
14,753.85 (0.26%)
NIFTY PHARMA
22,808.70 (0.11%)
NIFTY MEDIA
22,808.70 (0.11%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

   Quarterly Results
Change Company Name
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 500124 ISIN Demat INE089A01031 Book Value 377.56 NSE Symbol DRREDDY Dividend Yield (%) 0.62 Market Cap ( Cr.) 106,803.47 P/E 19.78 EPS 64.68 Face Value 1

Particulars (₹ Cr)Sep 2025Jun 2025Mar 2025Dec 2024
Gross Sales/Income from operations 4602.97788.75546.34997.8
Less: Excise duty 0.000.000.000.00
Net Sales/Income from operations 4,602.907,788.705,546.304,997.80
Other Operating Income 15.7020.8016.6017.20
Total Income from operations (net) 4,618.607,809.505,562.905,015.00
Total Expenses 4,433.104,252.304,384.404,087.70
Cost of Sales 1,730.501,586.401,559.501,483.10
Employee Cost 867.90887.30797.10794.40
Depreciation, amortization and depletion expense 294.80279.80264.50265.10
Provisions & Write Offs 3.700.00103.600.00
Administrative and Selling Expenses 0.000.000.000.00
Other Expenses 1,536.201,498.801,659.701,545.10
Pre Operation Expenses Capitalised 0.000.000.000.00
Profit from operations before other income, finance costs and exceptional items 185.503,557.201,178.50927.30
Other Income 364.20398.30414.40235.40
Profit from ordinary activities before finance costs and exceptional items 549.703,955.501,592.901,162.70
Finance Costs 33.4019.2031.1043.30
Profit from ordinary activities after finance costs but before exceptional items 516.303,936.301,561.801,119.40
Exceptional Items 0.000.000.000.00
Other Adjustments Before Tax 0.000.000.000.00
Profit from ordinary activities before tax 516.303,936.301,561.801,119.40
Total Tax 129.00975.10361.10270.00
Net profit from Ordinary Activities After Tax 387.302,961.201,200.70849.40
Profit / (Loss) from Discontinued Operations 0.000.000.000.00
Net profit from Ordinary Activities/Discontinued Operations After Tax 387.302,961.201,200.70849.40
Extraordinary items 0.000.000.000.00
Other Adjustments After Tax 0.000.000.000.00
Net Profit after tax for the Period 387.302,961.201,200.70849.40
Other Comprehensive Income -88.7018.5070.60-58.30
Total Comprehensive Income 298.602,979.701,271.30791.10
Equity 83.5083.5083.4083.40
Reserve & Surplus 0.000.000.000.00
Face Value 1.001.001.001.00
EPS:     
EPS before Exceptional/Extraordinary items-Basic 4.6535.5914.4110.20
EPS before Exceptional/Extraordinary items-Diluted 4.6535.5414.3910.18
EPS after Exceptional/Extraordinary items-Basic 4.6535.5914.4110.20
EPS after Exceptional/Extraordinary items-Diluted 4.6535.5414.3910.18
Book Value (Unit Curr.) 0.000.000.000.00
Dividend Per Share(Rs.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
No. of Employees 0.000.000.000.00
Debt Equity Ratio 0.000.000.000.00
Debt Service Coverage Ratio 0.000.000.000.00
Interest Service Coverage Ratio 0.000.000.000.00
Debenture Redemption Reserve (Rs cr) 0.000.000.000.00
Paid up Debt Capital (Rs cr) 0.000.000.000.00
  • Copyright © 2024   INVES 21
  • Charts are powered by TradingView.
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)